These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12122920)

  • 21. Serotonin receptor subtypes involved in the spinal antinociceptive effect of 5-HT in rats.
    Bardin L; Lavarenne J; Eschalier A
    Pain; 2000 May; 86(1-2):11-8. PubMed ID: 10779655
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physiology and pathophysiology of the 5-HT3 receptor.
    Färber L; Haus U; Späth M; Drechsler S
    Scand J Rheumatol Suppl; 2004; 119():2-8. PubMed ID: 15515404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence that spinal 5-HT1, 5-HT2 and 5-HT3 receptor subtypes modulate responses to noxious colorectal distension in the rat.
    Danzebrink RM; Gebhart GF
    Brain Res; 1991 Jan; 538(1):64-75. PubMed ID: 2018933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of peripheral 5-HT
    Nascimento EB; Romero TRL; Dutra MMGB; Fiebich BL; Duarte IDG; Coelho MM
    Biomed Pharmacother; 2021 Mar; 135():111210. PubMed ID: 33453675
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5-HT3 receptor antagonists for the prevention of chemotherapy-induced nausea and vomiting. A comparison of their pharmacology and clinical efficacy.
    Gregory RE; Ettinger DS
    Drugs; 1998 Feb; 55(2):173-89. PubMed ID: 9506240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-hydroxytryptamine3 (5-HT3) receptors mediate spinal 5-HT antinociception: an antisense approach.
    Paul D; Yao D; Zhu P; Minor LD; Garcia MM
    J Pharmacol Exp Ther; 2001 Aug; 298(2):674-8. PubMed ID: 11454930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review article: 5-hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications.
    Talley NJ
    Aliment Pharmacol Ther; 1992 Jun; 6(3):273-89. PubMed ID: 1600046
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Short-term treatment of primary fibromyalgia with the 5-HT3-receptor antagonist tropisetron. Results of a randomized, double-blind, placebo-controlled multicenter trial in 418 patients.
    Färber L; Stratz TH; Brückle W; Späth M; Pongratz D; Lautenschläger J; Kötter I; Zöller B; Peter HH; Neeck G; Welzel D; Müller W;
    Int J Clin Pharmacol Res; 2001; 21(1):1-13. PubMed ID: 11708570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analgesic effects of 5-HT3 receptor antagonists.
    Riering K; Rewerts C; Zieglgänsberger W
    Scand J Rheumatol Suppl; 2004; 119():19-23. PubMed ID: 15515407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spectrum of use and tolerability of 5-HT3 receptor antagonists.
    Haus U; Späth M; Färber L
    Scand J Rheumatol Suppl; 2004; 119():12-8. PubMed ID: 15515406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [5-HT3 receptor antagonists as a new therapeutic principle in rheumatology?].
    Pongratz D
    Z Rheumatol; 2001 Feb; 60(1):47-8. PubMed ID: 11263014
    [No Abstract]   [Full Text] [Related]  

  • 32. Differential pharmacotherapy for subgroups of fibromyalgia patients with specific consideration of 5-HT3 receptor antagonists.
    Seidel MF; Müller W
    Expert Opin Pharmacother; 2011 Jun; 12(9):1381-91. PubMed ID: 21323622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects on muscle pain by intramuscular injection of granisetron in patients with fibromyalgia.
    Ernberg M; Lundeberg T; Kopp S
    Pain; 2003 Feb; 101(3):275-282. PubMed ID: 12583870
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential influence of two serotonin 5-HT3 receptor antagonists on spinal serotonin-induced analgesia in rats.
    Bardin L; Jourdan D; Alloui A; Lavarenne J; Eschalier A
    Brain Res; 1997 Aug; 765(2):267-72. PubMed ID: 9313899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of fibromyalgia with tropisetron, a 5HT3 serotonin antagonist: a pilot study.
    Papadopoulos IA; Georgiou PE; Katsimbri PP; Drosos AA
    Clin Rheumatol; 2000; 19(1):6-8. PubMed ID: 10752491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 5-HT3 and 5-HT4 receptors and cholinergic and tachykininergic neurotransmission in the guinea-pig proximal colon.
    Briejer MR; Schuurkes JA
    Eur J Pharmacol; 1996 Jul; 308(2):173-80. PubMed ID: 8840129
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agonist- and antagonist-induced up-regulation of surface 5-HT3 A receptors.
    Morton RA; Baptista-Hon DT; Hales TG; Lovinger DM
    Br J Pharmacol; 2015 Aug; 172(16):4066-77. PubMed ID: 25989383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The 5-HT3 receptor as a therapeutic target.
    Thompson AJ; Lummis SC
    Expert Opin Ther Targets; 2007 Apr; 11(4):527-40. PubMed ID: 17373882
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of 5-HT3 receptors in activation of abdominal sympathetic C fibre afferents during ischaemia in cats.
    Fu LW; Longhurst JC
    J Physiol; 1998 Jun; 509 ( Pt 3)(Pt 3):729-40. PubMed ID: 9596795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Facilitatory actions of serotonin type 3 receptors on GABAergic inhibitory synaptic transmission in the spinal superficial dorsal horn.
    Fukushima T; Ohtsubo T; Tsuda M; Yanagawa Y; Hori Y
    J Neurophysiol; 2009 Sep; 102(3):1459-71. PubMed ID: 19369358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.